Found: 14
Select item for more details and to access through your institution.
PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence in Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 5, p. 3114, doi. 10.1245/s10434-022-12784-7
- By:
- Publication type:
- Article
ASO Visual Abstract: PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence for Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
ASO Visual Abstract: Insurance Authorization Barriers in Patients Undergoing Cytoreductive Surgery and HIPEC.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Insurance Authorization Barriers in Patients Undergoing Cytoreductive Surgery and HIPEC.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 1, p. 417, doi. 10.1245/s10434-022-12437-9
- By:
- Publication type:
- Article
ASO Visual Abstract: Phase II Prospective Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy with and without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
- Published in:
- 2022
- By:
- Publication type:
- Abstract
ASO Author Reflections: The Utility of Circulating-Tumor DNA in Selecting Patients for Locoregional, Metastases-Directed Therapies in Oligometastatic Foregut Adenocarcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 7, p. 4593, doi. 10.1245/s10434-022-11404-8
- By:
- Publication type:
- Article
Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 7, p. 4583, doi. 10.1245/s10434-021-11249-7
- By:
- Publication type:
- Article
Jonathan Letterman, MD: The Surgeon-Soldier & His Reform of Battlefield Medicine.
- Published in:
- 2018
- By:
- Publication type:
- journal article
ASO Visual Abstract: Venous Thromboembolism in Peritoneal Mesothelioma—Uncovering the Hidden Risk.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
ASO Visual Abstract: Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 1, p. 645, doi. 10.1245/s10434-023-14318-1
- By:
- Publication type:
- Article
Design and Implementation of a Learner-Centered Self-Paced Peritoneal Oncology Education Program.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Early Integrated Palliative Care Within a Surgical Oncology Clinic.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2341928, doi. 10.1001/jamanetworkopen.2023.41928
- By:
- Publication type:
- Article
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Where do we stand?
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 495, doi. 10.1002/cncr.34567
- By:
- Publication type:
- Article